Robert Axtell to Encephalomyelitis, Autoimmune, Experimental
This is a "connection" page, showing publications Robert Axtell has written about Encephalomyelitis, Autoimmune, Experimental.
Connection Strength
9.376
-
Interferon-ß Intensifies Interleukin-23-Driven Pathogenicity of T Helper Cells in Neuroinflammatory Disease. Cells. 2021 08 20; 10(8).
Score: 0.746
-
Pertussis Toxin Inhibits Encephalitogenic T-Cell Infiltration and Promotes a B-Cell-Driven Disease during Th17-EAE. Int J Mol Sci. 2021 Mar 13; 22(6).
Score: 0.723
-
CNS Autoimmune Responses in BCMA-Deficient Mice Provide Insight for the Failure of Atacicept in MS. Neurol Neuroimmunol Neuroinflamm. 2021 05; 8(3).
Score: 0.722
-
ELTD1 as a biomarker for multiple sclerosis: Pre-clinical molecular-targeted studies in a mouse experimental autoimmune encephalomyelitis model. Mult Scler Relat Disord. 2021 Apr; 49:102786.
Score: 0.716
-
Transcriptomics and proteomics reveal a cooperation between interferon and T-helper 17 cells in neuromyelitis optica. Nat Commun. 2020 06 05; 11(1):2856.
Score: 0.686
-
B cell function impacts the efficacy of IFN-ß therapy in EAE. J Neuroimmunol. 2020 01 15; 338:577106.
Score: 0.659
-
Emerging Role of Follicular T Helper Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. Int J Mol Sci. 2018 Oct 19; 19(10).
Score: 0.612
-
Role of TFH Cells in Promoting T Helper 17-Induced Neuroinflammation. Front Immunol. 2018; 9:382.
Score: 0.586
-
IFN-ß treatment requires B cells for efficacy in neuroautoimmunity. J Immunol. 2015 Mar 01; 194(5):2110-6.
Score: 0.474
-
Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein. Mult Scler. 2012 Apr; 18(4):398-408.
Score: 0.386
-
T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis. Nat Med. 2010 Apr; 16(4):406-12.
Score: 0.338
-
Gaining entry to an uninflamed brain. Nat Immunol. 2009 May; 10(5):453-5.
Score: 0.318
-
Type 1 interferons cool the inflamed brain. Immunity. 2008 May; 28(5):600-2.
Score: 0.296
-
CD5-CK2 binding/activation-deficient mice are resistant to experimental autoimmune encephalomyelitis: protection is associated with diminished populations of IL-17-expressing T cells in the central nervous system. J Immunol. 2006 Dec 15; 177(12):8542-9.
Score: 0.269
-
Cutting edge: critical role for CD5 in experimental autoimmune encephalomyelitis: inhibition of engagement reverses disease in mice. J Immunol. 2004 Sep 01; 173(5):2928-32.
Score: 0.230
-
Amelioration of ongoing experimental autoimmune encephalomyelitis with fluoxetine. J Neuroimmunol. 2017 12 15; 313:77-81.
Score: 0.143
-
Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis. Mol Vis. 2016; 22:1503-1513.
Score: 0.135
-
Myelin-specific Th17 cells induce severe relapsing optic neuritis with irreversible loss of retinal ganglion cells in C57BL/6 mice. Mol Vis. 2016; 22:332-41.
Score: 0.129
-
Defective sphingosine 1-phosphate receptor 1 (S1P1) phosphorylation exacerbates TH17-mediated autoimmune neuroinflammation. Nat Immunol. 2013 Nov; 14(11):1166-72.
Score: 0.108
-
The interdependent, overlapping, and differential roles of type I and II IFNs in the pathogenesis of experimental autoimmune encephalomyelitis. J Immunol. 2013 Sep 15; 191(6):2967-77.
Score: 0.107
-
Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity. Clin Rev Allergy Immunol. 2013 Apr; 44(2):114-20.
Score: 0.104
-
CD5-dependent CK2 activation pathway regulates threshold for T cell anergy. J Immunol. 2012 Sep 15; 189(6):2918-30.
Score: 0.100
-
Reversal of paralysis and reduced inflammation from peripheral administration of ß-amyloid in TH1 and TH17 versions of experimental autoimmune encephalomyelitis. Sci Transl Med. 2012 Aug 01; 4(145):145ra105.
Score: 0.100
-
Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice. J Exp Med. 2012 Jul 02; 209(7):1325-34.
Score: 0.099
-
Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol Ther. 2011 10; 19(10):1769-79.
Score: 0.094
-
Peroxisome proliferator-activated receptor delta limits the expansion of pathogenic Th cells during central nervous system autoimmunity. J Exp Med. 2010 Aug 02; 207(8):1599-608.
Score: 0.086
-
Angiotensin II sustains brain inflammation in mice via TGF-beta. J Clin Invest. 2010 Aug; 120(8):2782-94.
Score: 0.086
-
Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci U S A. 2010 Feb 09; 107(6):2580-5.
Score: 0.084
-
Lithium prevents and ameliorates experimental autoimmune encephalomyelitis. J Immunol. 2008 Jul 01; 181(1):338-45.
Score: 0.075
-
Critical requirement of CD11b (Mac-1) on T cells and accessory cells for development of experimental autoimmune encephalomyelitis. J Immunol. 2005 Nov 15; 175(10):6327-33.
Score: 0.063
-
mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell Function. J Immunol. 2015 Aug 15; 195(4):1470-9.
Score: 0.030
-
Th17 cells induce Th1-polarizing monocyte-derived dendritic cells. J Immunol. 2013 Aug 01; 191(3):1175-87.
Score: 0.026
-
Therapeutic effects of systemic administration of chaperone aB-crystallin associated with binding proinflammatory plasma proteins. J Biol Chem. 2012 Mar 23; 287(13):9708-9721.
Score: 0.024
-
IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-ß in multiple sclerosis. Sci Transl Med. 2011 Jul 27; 3(93):93ra68.
Score: 0.023